Tens of millions of Medicare sufferers shall be eligible for GLP-1 weight-loss medicine like Ozempic and Wegovy at a cut-rate $50 per 30 days below an upcoming authorities program.
As much as 14 million Medicare recipients are chubby and will qualify for the discounted drug program — often known as the Medicare GLP-1 Bridge — which rolls out July 1 and continues by way of 2027.
It’s a part of a program President Trump introduced in November to drastically decrease drug prices for People, with the president hanging a cope with a few of the main GLP-1 makers to offer the medicine at a low “most favored nation” charge.
Ozempic retails for greater than $1,000 a month, and the weight-loss variant of the drug, Wegovy, is listed for $1,350. There are some work-arounds to save cash, however no low-cost generic variations as a result of they’re nonetheless new medicines below patent.
That makes the GLP-1 Bridge program a uncommon alternative for individuals to get their palms on the weight-loss medicine at a small fraction of the same old worth.
Right here is every part it is advisable to know concerning the new program.
What’s the Medicare GLP-1 Bridge?
GLP-1 prescriptions have been beforehand out there for Medicare sufferers coping with circumstances like diabetes, sleep apnea, and heart problems — however weren’t out there for weight reduction, the remedy that’s made headlines as sufferers shed dozens of kilos on the drug.
The Medicare Bridge widens which Medicare customers qualify for GLP-1 prescriptions — making prescriptions out there for sufferers who need to take it for weight reduction.
This program is a short-term pilot to gauge the feasibility of a bigger program — accounting for the “Bridge” a part of the title.
A everlasting plan for GLP-1s might start rolling out in 2028.
How lengthy will this system run, and what occurs after?
The Bridge program runs from July 1, 2026, to Dec. 31, 2027.
It stays unclear if it should proceed after 2027, because the Bridge program’s goal is to see how a lot demand there shall be for GLP-1s so insurance coverage corporations can gauge whether or not they may take part.
Insurer participation is important to make a long-term GLP-1 weight-loss Medicare program possible, as the federal government would rely upon them to subsidize the prices of the large of the GLP-1s reductions.
The federal government can be on the hook for billions of {dollars} if insurers don’t join, with the Congressional Price range Workplace estimating this system would price taxpayers about $35 billion from simply 2026 to 2034, in keeping with the New York Instances.
Such a price might forestall a long-term program from being reasonably priced — particularly because the federal authorities seems to be to tamp down on entitlement spending.
Who qualifies for this system?
Most Medicare sufferers 65 years and older who’re chubby qualify for this system.
Meaning you have to have a physique mass index (BMI) of 35 to routinely qualify, or a BMI of 27 and an obesity-associated situation like pre-diabetes and coronary heart illness, in keeping with NPR.
You will need to additionally been enrolled in a Medicare Half D plan, which covers prescription medicines.
If you’re already taking a GLP-1 by way of Medicare for an additional situation, you could not qualify for the $50 copay.
What GLP-1 medicine are lined by the Bridge program?
Three GLP-1s shall be out there below this system — Zepbound, Foundayo and Wegovy.
Foundayo and Wegovy can be found as tablet, slightly than injectables.
Ozempic, which is main used to deal with diabetes and never for weight reduction, will not be a part of this system.
The medicine are sometimes very costly, however shall be out there below the Bridge program for a fraction of their standard price.
Zepbound sometimes prices $699 per 30 days — if sufferers pay money.
Wegovy, a tablet, prices between $199 and $399 per 30 days.
And the Foundayo tablet can price as much as $349 per 30 days.
The medicine are from the makers Eli Lilly and Novo Nordisk, which have been central to President Trump’s “most favored nation” deal.
How do you take part in this system?
Sufferers won’t undergo their standard Medicare Half D program to acquire GLP-1 prescriptions by way of the Bridge program.
As an alternative, they have to acquire a prior-authorization from a health care provider who will submit that paperwork by way of the platform Humana.
Any physician can present the prior-authorization — they don’t have to be Medicare suppliers.
Sufferers will then have the ability to fill their prescriptions at a pharmacy, the place they may solely need to pay this system’s $50 co-pay.
What are some program downsides?
The Bridge program supplies offers solely on the weight-loss medicine — not one of the counseling that sometimes accompanies any person making an attempt to shed severe kilos to enhance their well being, Axios reported.
With the Bridge program offering weight-loss medicine for individuals older 65, that would change into problematic for sufferers who lose an excessive amount of weight however don’t have accompanying remedy and counseling.
Making a significant distinction in well being additionally requires greater than only a drug — vitamin, weight-reduction plan and train are required to maintain kilos off and keep wholesome, medical doctors say.
Most GLP-1 customers additionally sometimes achieve weight again once they cease taking the drug except they’ve made important modifications to their life-style in tandem — so if the Bridge program doesn’t proceed after it ends in 2027, that would have well being penalties for sufferers.
